Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial.

ABSTRACT:

SUBMITTER: Fennell DA 

PROVIDER: S-EPMC9386392 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature